Role of Ayurveda in prevention of Covid-19 pandemic - An Integrative Overview
Abstract
Introduction: Recently all world is suffering from Pandemic Covid 19. COVID-19 is an infectious disease caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) that is novel corona virus. First case was detected in Wuhan, China. The symptoms are similar as like flu. Most common symptoms are fever, dry cough, breathlessness, sore throat, weakness, bodyaches. These symptoms vary according to individuals. COVID 19 is declared as Pandemic. In Ayurveda, Pandemic is explained in Charaka Samhita Viman Sthana under Janpadodhwansniya Adhyaya. There is no medication for Covid 19. So, we can prevent and defend this disease by boosting own immunity. Ayurveda explained immunity under the heading of Vyadhikshamatwa. In Ayurveda various types of regimens like Dinacharya, Ritucharya, Aharavidhi, Rasayana Chikitsa, Vyayama, Yoga, Pranayama. These all are very much helpful to enhance the immunity. Methods: In this article, information from contemporary texts of Ayurveda in view of Vyadhikshamatva and immunity have been documented to understand treatment approach of Ayurvedic science. Result: The Pandemic like Covid 19 is difficult to manage in current days. But it is possible to prevent and manage by boosting the immunity. Conclusion: This pandemic of Corona virus disease SARS COV2 has no treatment and vaccination available till now. Only prevention is the way by adoption of social distancing as the contaminating rate is very high. So one should understand the importance of healthy life style, good diet habits and daily exercise etc. to acquire immunity. Immunity can be acquired with some herbs and medicines, by following regimen, Proper Rasayana etc. Hence, it is necessary to aware people about health hygine, following healthy regimen, boosting the immunity which is explained in Ayurveda. In the present review article, an attempt has been made to present concept of Vyadhikshamatva specially in current Pandemic COVID 19.
Downloads
References
https://www.health.gov.au/sites/default/files/docume nts/2020/03/coronavirus-Covid19 information- onsocial distancing pdf 16 march 2020.
Chowdhury MA, et al. Immune response in COVID-19: A review. J Infect Public Health (2020), https://doi.org/10.1016/j.jiph.2020.07.001)
Gobalenya AE, Baker SC et al. "The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2". Nature Microbiology, (March 2020). 5 (4): 536–544
"CoV2020". GISAID Epiflu DB. Archived from the original on 12 January 2020, Retrieved 12 January 2020.
Fox D "What you need to know about the Wuhan coronavirus". Nature. (24 January 2020). ISSN 0028- 0836. doi:10.1038/d41586-020-00209-y.
Chen N, Zhou M et al. "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study". The Lancet.(15 February 2020). 395 (10223): 507–513
"How COVID-19 Spreads". U.S. Centres for Disease Control and Prevention (CDC). 27 January 2020.
Xu X, Chen P, et al. "Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission". Science China Life Sciences. (March 2020). 63 (3): 457–460.
Wrapp D, Wang N, et al. "Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation". Science. (February 2020). 367 (6483): 1260–1263.
Journal of Ayurveda and Integrated Medical Sciences (JAIMS) retains the copyright of the contents of this journal but grant the readers the right to use the contents with terms and conditions under a creative common attribution licenses 4 of Attribution, Share Alike and Non-commercial type (CC BY-NC-SA) that allows copy, distribute, display, and perform the work and make derivative works based on it only for non-commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.